Mortgage Blog How a team from closed East Bay biotech Plexxicon is zeroing in on a new cancer target firststargroup November 22, 2022 Opna Bio is backed with $38 million as well as drugs brought over from Plexxikon.
Opna Bio is backed with $38 million as well as drugs brought over from Plexxikon.
